Please enable Javascript
Paul Peter Tak
Paul Peter Tak
Articles by Paul Peter Tak
Paul Peter Tak, CEO of Candel Therapeutics, Discusses the Treatment of Glioblastoma
Paul Peter Tak
Oncology
|
August 26, 2024
Paul Peter Tak discusses CAN-3110, a promising therapy which may increase survival in people with glioblastoma.
View More